dapoxetine
Trade name: priligy
Dapoxetine, sold under the brand name Priligy among others, is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of premature ejaculation (PE) in men ages 18 to 64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin's action at the postsynaptic cleft, and as a consequence promoting ejaculatory delay. As a member of the SSRI family, dapoxetine was initially created as an antidepressant. However, unlike other SSRIs, dapoxetine is absorbed and eliminated rapidly in the body. Its fast-acting property makes it suitable for the treatment of PE, but not as an antidepressant. — Wikipedia
Clinical trial activity
24 trials · 21 clinical orgs · 0 marketing orgs
Earliest trial started Jun 1, 2003 (NCT00211107)
Timeline
Indications
Approved for
Mechanism of action
- Serotonin transporterINHIBITOR
SLC6A4 inhibitor
Dapoxetine is a selective serotonin reuptake inhibitor (SSRI). It blocks axonal re-uptake of serotonin (5-HT) from the synapse by 5-HT transporters, resulting in enhanced 5-HT neurotransmission, stimulation of post-synaptic membrane 5-HT2C receptors and ejaculatory delay.
Dapoxetine is a potent selective serotonin reuptake inhibitor (SSRI) (pKi = 8 nM). Equilibrium radioligand binding studies using human cells demonstrate that dapoxetine binds to serotonin (5-HT), norepinephrine (NE) and dopamine (DA) reuptake transporters and inhibits uptake in the following order of potency: NE<5-HT>>DA.
Chemistry & pharmacology
SMILES
CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1- Mol. weight
- 305.42 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110900 ↗
- WikipediaDapoxetine ↗
- ChEMBLCHEMBL2106574 ↗
Also known as
- dapoxetina
- dapoxetina
- dapoxetine
- dapoxetine
- dapoxetine
- dapoxetine
- dapoxetine
- dapoxetine
- dapoxetine
- dapoxetine
- dapoxetine hcl
- dapoxetine hcl
- dapoxetine hydrochloride
- dapoxetine hydrochloride
- dapoxetine hydrochloride
- dapoxetine hydrochloride
- dapoxetine hydrochloride
- dapoxetinum
- dapoxetinum
- ly 210448
- ly-210448
- ly-210448
- n,n-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)benzenemethanamine
- priligy
- priligy
- priligy
- priligy
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07081659 | Phase 2/Phase 3 (Phase 3) | Mar 1, 2024 | Benha University |
| NCT05556083 | Phase 2 | Oct 1, 2022 | Al Azhar University |
| NCT06425224 | Phase 3 | Jun 15, 2022 | Boston Medical Group |
| NCT04850703 | Phase 1/Phase 2 (Phase 2) | Feb 2, 2021 | Hereford Hospital, Sexual Salud Valclinic, Spanish Foundation for Neurometrics Development |
| NCT04361305 | Phase 3 | Jun 3, 2020 | Jiao Tong University |
| NCT04703127 | Phase 3 | Mar 30, 2020 | Sohag University |
| NCT04085354 | Phase 3 | Feb 10, 2019 | Sohag University |
| NCT03583112 | N/A | Jul 10, 2018 | The Northwest Women's and Children's Hospital, Xidian University |
| NCT03177746 | Phase 4 | Jul 3, 2017 | NeuTec Pharma |
| NCT02939495 | Phase 4 | Oct 1, 2016 | Bagcilar Research and Training Hospital, NeuTec Pharma |
| NCT02844998 | N/A | Jan 1, 2015 | University of Ankara |
| NCT02485041 | Phase 1 | Nov 1, 2014 | Chonbuk National University, SK Chemicals |
| NCT02485028 | Phase 1 | Oct 1, 2013 | SK Chemicals, Sungkyunkwan University |
| NCT01928563 | Phase 1 | Sep 1, 2013 | Dong-A Pharmaceutical, University of Ulsan |
| NCT01366664 | Phase 1 | Apr 1, 2011 | Johnson and Johnson |
| NCT01419470 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2011 | Yuhan Pharmaceutical Company |
| NCT01230762 | Phase 3 | Oct 28, 2010 | Alza |
| NCT01063881 | Phase 3 | May 1, 2010 | Johnson and Johnson |
| NCT01063855 | Phase 3 | Apr 1, 2010 | Johnson and Johnson |
| NCT00211094 | Phase 3 | Sep 15, 2005 | Alza |
Organizations
Research & Development (21)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 6 | 6 | 2 | 2004 |
| Alza | For profit | 3 | 3 | 1 | 2003 |
| NeuTec Pharma | For profit | 2 | 2 | 1 | 2016 |
| SK Chemicals | For profit | 2 | 2 | 1 | 2013 |
| Sohag University | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Al Azhar University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Bagcilar Research and Training Hospital | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Benha University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Boston Medical Group | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Dong-A Pharmaceutical | For profit | 1 | 1 | 1 | 2013 |
| Hereford Hospital | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Sexual Salud Valclinic | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Spanish Foundation for Neurometrics Development | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| The Northwest Women's and Children's Hospital | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Ankara | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Xidian University | Academic/Hospital | 1 | 1 | 1 | 2018 |